NIH-funded research R01 grant

Understanding how Barrett's Esophagus may progress to cancer

Official title: Modeling Neoplastic Progression in Barrett's Esophagus - Renewal -2

Funded at Arizona State University-Tempe Campus · NIH-11014342 · Data updated 2026-11-12

This study is looking at how cells in Barrett's Esophagus change over time to better understand the risk of developing esophageal cancer, helping doctors give more accurate predictions for patients.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionArizona State University-Tempe Campus
NIH-funded
Lab location1 site (Tempe, United States)
Project startFebruary 7, 2023
Project endJanuary 31, 2028
Funding year2025
Award (this year)$429,747
NIH project number5R01CA140657-13
Project IDNIH-11014342 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with Barrett's Esophagus who are concerned about their risk of developing esophageal adenocarcinoma.

Less likely to help

Patients without a diagnosis of Barrett's Esophagus or those who have already developed esophageal adenocarcinoma may not benefit from this research.

What this research studies

This research investigates the risk of esophageal adenocarcinoma in patients with Barrett's Esophagus by examining the evolutionary dynamics at the cellular level. The study aims to quantify how quickly and in what manner cells evolve in Barrett's tissue, which may help predict the likelihood of cancer development. By analyzing biopsies over time and space, researchers will assess various factors that influence cellular evolution, such as mutation rates and stem cell dynamics. This innovative approach seeks to provide a more reliable risk assessment for patients.

Why it matters

Potential benefit: If successful, this research could lead to better risk stratification for patients with Barrett's Esophagus, allowing for more personalized monitoring and treatment strategies.

How similar studies have gone: While the approach of measuring cellular evolution in this context is relatively novel, similar methodologies in cancer research have shown promise in predicting cancer risk and progression.

Where this research is happening

  • Arizona State University-Tempe Campus
    Tempe, United States
    Active

Researchers

  • Principal investigator: Maley, Carlo — Arizona State University-Tempe Campus
  • Study coordinator: Maley, Carlo

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.